Hamamatsu Medical Photonics Foundation

Hamamatsu Photonics develops and commercializes advanced photonic devices, optical sensors, light sources, and imaging systems widely used in scientific research, clinical diagnostics (notably digital pathology), drug discovery screening assays, and industrial applications. Their NanoZoomer line of digital slide scanners has received FDA clearance for primary diagnosis in surgical pathology when paired with Indica Labs' HALO AP Dx platform. The company continues to innovate with new products such as the CYTOQUBE cell analyzer for high-throughput live cell imaging.[8][10]

No therapeutics or drugs are developed by this company; their focus is on enabling technologies.

No clinical trial results are applicable as they do not develop drugs or biologics.

Their products are widely adopted across academic research centers, hospitals/labs using digital pathology workflows, pharmaceutical R&D labs conducting high-content screening assays, and various industrial sectors.[1][3][4]